Biocept

-$0.04 (-0.87%) Today
-$0.07 (-1.53%) As of 8:50 AM UTC after-hours

Why Robinhood?

You can buy or sell Biocept and other stocks, options, and ETFs commission-free!

About BIOC

Biocept, Inc. Common Stock, also called Biocept, is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells.

CEO
Michael W. Nall
Employees
134
Headquarters
San Diego, California
Founded
1997

BIOC Key Statistics

Market Cap
61.25M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
213.90K
High Today
$4.65
Low Today
$4.50
Open Price
$4.59
Volume
149.16K
52 Week High
$13.00
52 Week Low
$3.46

BIOC News

MarketWatchJun 9

Biocept Developing System to Track Covid-19 Tests

By Chris Wack Biocept Inc. said Wednesday it was working with CLEARED4 to develop a system for tracking and managing Covid-19 testing requirements and test res

BIOC Earnings

-$0.47
-$0.25
-$0.03
$0.19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure